PPC
MCID: PRM126
MIFTS: 51

Primary Peritoneal Carcinoma (PPC) malady

Cancer category

Summaries for Primary Peritoneal Carcinoma

Sources:
64Wikipedia, 33MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:64 Primary peritoneal cancer or carcinoma is also known as: serous surface papillary carcinoma, primary... more...

MalaCards: Primary Peritoneal Carcinoma, also known as serous surface papillary carcinoma, is related to peritoneal carcinoma and papillary carcinoma, and has symptoms including anomalies of the abdominal wall, nausea/vomiting/regurgitation/merycism/hyperemesis and acute abdominal pain/colic. An important gene associated with Primary Peritoneal Carcinoma is BRCA1 (breast cancer 1, early onset), and among its related pathways are TGF-Beta Pathway and Nucleotide Excision Repair. The compounds cycloheximide and resveratrol have been mentioned in the context of this disorder. Affiliated tissues include lymph node, brain and colon, and related mouse phenotypes are limbs/digits/tail and skeleton.

Aliases & Classifications for Primary Peritoneal Carcinoma

Sources:
49Orphanet, 61UMLS, 26ICD10 via Orphanet
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer


Characteristics (Orphanet epidemiological data):

49
serous surface papillary carcinoma:
Age of onset: Adulthood; Age of death: Normal


Aliases & Descriptions:

primary peritoneal carcinoma 49 61
serous surface papillary carcinoma 49 61
extra-ovarian primary peritoneal carcinoma 49
primary peritoneal serous carcinoma 49
eoppc 49
ppc 49


External Ids:

ICD10 via Orphanet26 C48.2

Related Diseases for Primary Peritoneal Carcinoma

Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Primary Peritoneal Carcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 181)
idRelated DiseaseScoreTop Affiliating Genes
1peritoneal carcinoma31.6BRCA2, BRCA1
2papillary carcinoma30.8BRCA2, MUC16, RET, PGR, ERBB2
3adenocarcinoma30.4MUC16, EGFR, BRCA2, BRCA1, PGR, CXCL10
4tuberculosis30.3IFNG, CXCL10, IL10
5ovary papillary carcinoma10.5
6papillary serous adenocarcinoma10.4
7ovarian epithelial cancer10.3
8primary syphilis10.3
9syphilis10.3
10tertiary syphilis10.3
11pleomorphic carcinoma10.1
12lymphangitis10.1
13trophoblastic neoplasm10.1
14intestinal lymphangiectasia10.1
15primary intestinal lymphangiectasia10.1
16posterior polar cataract10.0
17herpes simplex10.0CXCL10
18hepatitis10.0CXCL10
19colon adenocarcinoma10.0CEACAM5
20biliary atresia10.0CXCL10
21arthropathy10.0CXCL10
22severe acute respiratory syndrome10.0CXCL10
23cystadenoma10.0BRCA1
24mycosis fungoides10.0CXCL10
25peritonitis10.0MUC16
26wilms tumor10.0BRCA2
27breast-ovarian cancer, familial, 210.0BRCA2
28pleurisy10.0MUC16
29dermatomyositis10.0MUC16
30neurofibromatosis10.0RET
31hemangioma10.0RET
32leiomyoma10.0PGR
33meningioma10.0PGR
34von hippel-lindau disease10.0RET
35angiomyolipoma10.0PGR
36parathyroid carcinoma10.0RET
37hyperparathyroidism10.0RET
38peutz-jeghers syndrome10.0BRCA2
39uterine carcinosarcoma10.0ERBB2
40anaplastic large cell lymphoma10.0MUC16
41dementia10.0CXCL10
42struma ovarii10.0MUC16
43phaeochromocytoma10.0RET
44pulmonary fibrosis10.0IL8
45rhinitis10.0IL8
46papilloma10.0TP53
47osteosarcoma10.0TP53
48connective tissue disease10.0IL10
49adenofibroma10.0MUC16
50rhabdomyosarcoma10.0TP53

Graphical network of the top 20 diseases related to Primary Peritoneal Carcinoma:



Diseases related to primary peritoneal carcinoma

Clinical Features for Primary Peritoneal Carcinoma

Sources:
49Orphanet
See all sources


Symptoms:

49 (show all 9)
  • anomalies of the abdominal wall
  • nausea/vomiting/regurgitation/merycism/hyperemesis
  • acute abdominal pain/colic
  • constipation
  • peritoneal diseases
  • neoplasms/tumors
  • ovary/fallopian tube neoplasm/tumor/carcinoma/cancer (excl. teratoma/germinoma)
  • weight loss/loss of appetite/break in weight curve/general health alteration
  • early death/lethality

Drugs & Therapeutics for Primary Peritoneal Carcinoma

Sources:
5CenterWatch, 42NIH Clinical Center, 6ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Primary Peritoneal Carcinoma

Drug clinical trials:

Search ClinicalTrials for Primary Peritoneal Carcinoma

Search NIH Clinical Center for Primary Peritoneal Carcinoma

Search CenterWatch for Primary Peritoneal Carcinoma

Genetic Tests for Primary Peritoneal Carcinoma

Anatomical Context for Primary Peritoneal Carcinoma

Sources:
33MalaCards
See all sources

MalaCards organs/tissues related to Primary Peritoneal Carcinoma:

33
Lymph node, Brain, Colon, Breast, Ovary, Endothelial

Animal Models for Primary Peritoneal Carcinoma or affiliated genes

Sources:
37MGI, 28inGenious Targeting Laboratory
See all sources

MGI Mouse Phenotypes related to Primary Peritoneal Carcinoma:

37 (show all 22)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000537110.5BRCA2
2MP:000539010.0BRCA1, BRCA2, PGR
3MP:00053699.8RET, TP53
4MP:00036319.7RET, ERBB2
5MP:00107719.6BRCA1, BRCA2, ERCC1, TP53
6MP:00053809.4RET, PGR, IL10, ERBB2
7MP:00053889.3BRCA1, EGFR, ERBB2, TP53
8MP:00053799.1BRCA1, BRCA2, IFNG, RET, TP53
9MP:00053679.1BRCA1, EGFR, RET
10MP:00053768.8BRCA1, BRCA2, IFNG, RET, PGR, CXCL10
11MP:00020068.7ERBB2, IL10, PGR, RET, EGFR, IFNG
12MP:00053898.5BRCA1, BRCA2, EGFR, RET, ERCC1, ERBB2
13MP:00030128.2TP53, IL10, PGR, RET, EGFR, IFNG
14MP:00053818.0BRCA1, BRCA2, IFNG, EGFR, RET, IL10
15MP:00028737.7BRCA1, BRCA2, IFNG, EGFR, RET, PGR
16MP:00053857.7BRCA1, IFNG, EGFR, RET, PGR, CXCL10
17MP:00053867.7BRCA1, BRCA2, IFNG, RET, PGR, IL10
18MP:00053787.4BRCA1, BRCA2, IFNG, EGFR, RET, IL10
19MP:00053977.3BRCA1, BRCA2, IFNG, EGFR, RET, PGR
20MP:00053877.3BRCA1, BRCA2, IFNG, EGFR, RET, PGR
21MP:00053847.3BRCA1, BRCA2, IFNG, EGFR, RET, PGR
22MP:00107687.2BRCA1, BRCA2, IFNG, EGFR, RET, PGR

Publications for Primary Peritoneal Carcinoma

Sources:
51PubMed
See all sources

Articles related to Primary Peritoneal Carcinoma:

(show top 50)    (show all 140)
idTitleAuthorsYear
1
A case of primary peritoneal carcinoma: evidence for a precursor in the fallopian tube. (24403495)
2014
2
Pegylated liposomal doxorubicin for platinum-resistant or refractory MA1llerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience. (23255889)
2013
3
Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182. (23791702)
2013
4
Primary peritoneal serous papillary carcinoma presenting as a single colonic mass without peritoneal dissemination. (23318853)
2013
5
A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study. (24361733)
2013
6
A case of extraovarian primary peritoneal carcinoma in an oophorectomized-hysterectomized patient: a diagnostic dilemma. (23578412)
2013
7
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma. (22960352)
2013
8
Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma. (23748176)
2013
9
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study. (22446624)
2012
10
High-grade primary peritoneal serous papillary carcinoma with a wide differential diagnosis: a diagnostic challenge. (23547430)
2012
11
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. (22047770)
2012
12
Cutaneous lymphangitis carcinomatosis metastasis of extra-ovarian primary peritoneal carcinoma. (22949038)
2012
13
Primary peritoneal serous papillary carcinoma: a clinical and pathological study. (21647781)
2011
14
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma. (21514634)
2011
15
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study. (20846715)
2010
16
Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. (19897383)
2010
17
Primary peritoneal carcinoma: a diagnostic dilemma. (20043172)
2010
18
An unexpected case of primary peritoneal carcinoma. (20589359)
2010
19
Brain metastases in epithelial ovarian and primary peritoneal carcinoma. (19574773)
2009
20
Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses. (18543395)
2008
21
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study. (18612157)
2008
22
Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma. (18226627)
2008
23
Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics. (18488238)
2008
24
Safety and efficacy of lenalidomide (Revlimid) in recurrent ovarian and primary peritoneal carcinoma. (17257661)
2007
25
Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma. (18076766)
2007
26
Colorectal resection in patients with ovarian and primary peritoneal carcinoma. (16730631)
2006
27
Primary peritoneal carcinoma: a rare neoplasm with pleomorphic trophoblastic morphology. (16907865)
2006
28
Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. (16769104)
2006
29
Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma. (15790449)
2005
30
Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: a Gynecologic Oncology Group Study. (15589582)
2005
31
Primary peritoneal carcinoma. (15559336)
2004
32
Bilateral palmar contractures as a paraneoplastic syndrome in primary peritoneal carcinoma. (14768760)
2004
33
Extraovarian primary peritoneal carcinoma in a child. (14752872)
2004
34
Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients. (15361188)
2004
35
Primary linitis plastica carcinoma of the colon accompanied by peritoneal abscess. (14595741)
2003
36
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women. (12504628)
2003
37
Axillary lymphadenopathy as the primary presentation of primary peritoneal carcinoma. (12592068)
2002
38
Primary peritoneal carcinoma presenting as adenocarcinoma on a Pap smear. A case report. (12497684)
2002
39
Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. (11737473)
2001
40
Extreme drug resistance assay and response to chemotherapy in patients with primary peritoneal carcinoma. (10738268)
2000
41
BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serous peritoneal carcinoma. (11059339)
2000
42
Primary peritoneal carcinoma presenting on routine papanicolaou smear. (10873414)
2000
43
Detecting abnormal cells from primary serous peritoneal carcinoma by Pap smear. (10579010)
1999
44
Solitary brain metastasis indicating recurrent primary peritoneal carcinoma. (10912420)
1999
45
Evidence that a "treatment-free interval of less than 6 months" does not equate with clinically defined platinum resistance in ovarian cancer or primary peritoneal carcinoma. (9692840)
1998
46
Extraovarian primary peritoneal carcinoma. (9644683)
1998
47
Primary peritoneal carcinoma can have multifocal origins: implications for prophylactic oophorectomy. (9625162)
1998
48
Biochemical characterization of primary peritoneal carcinoma cell adhesion, migration, and proteinase activity. (9367707)
1997
49
Lymphangitis carcinomatosa complicating primary malignant peritoneal mesothelioma. (8711691)
1996
50
Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. (8467455)
1993

Genetic Variations for Primary Peritoneal Carcinoma

Expression for genes affiliated with Primary Peritoneal Carcinoma

Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Primary Peritoneal Carcinoma

Search GEO for disease gene expression data for Primary Peritoneal Carcinoma.

Pathways for genes affiliated with Primary Peritoneal Carcinoma

Sources:
52QIAGEN, 54Reactome, 12EMD Millipore, 60Tocris Bioscience, 38NCBI BioSystems Database, 30KEGG, 56SinoBiological, 53R&D Systems, 50PharmGKB
See all sources

Pathways related to Primary Peritoneal Carcinoma according to GeneCards/GeneDecks:

(show all 33)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Hide members
10.2ERBB2
2
Hide members
10.0BRCA2, ERCC1
39.8TP53, BRCA1
4
Hide members
9.8TP53, ERBB2
59.8IL8, TP53
69.8ERCC1, BRCA2, BRCA1
79.6IL8, IFNG, BRCA1
8
DNA damage Role of Brca1 and Brca2 in DNA repair
Hide members
9.6BRCA1, BRCA2, TP53
99.6BRCA1, BRCA2, TP53
10
Hide members
9.6ERBB2, CXCL10, EGFR
119.5IFNG, IL10, IL8
129.5IL8, IL10, IFNG
139.5MIR195, MIR497
149.5ERBB2, EGFR, IFNG
159.5EGFR, CXCL10, TP53
169.4IFNG, IL8, TP53
17
Hide members
9.4IFNG, IL8, TP53
18
Hide members
9.4TP53, ERBB2, EGFR
199.4TP53, ERBB2, EGFR
209.4EGFR, ERBB2, TP53
21
Hide members
9.4EGFR, ERBB2, TP53
22
Hide members
9.3TP53, ERBB2, CXCL10, BRCA1
23
Hide members
9.3TP53, IL8, BRCA2, BRCA1
249.2TP53, EGFR, BRCA2, BRCA1
25
Hide members
9.2TP53, IL8, CXCL10, IFNG
26
Hide members
9.2EGFR, CXCL10, ERBB2, TP53
27
Hide members
9.2TP53, ERBB2, EGFR, BRCA2
28
Hide members
8.9BRCA1, BRCA2, EGFR, ERBB2, TP53
298.9TP53, ERBB2, EGFR, BRCA2, BRCA1
30
Hide members
8.9IFNG, CXCL10, IL10, IL8, TP53
318.7BRCA1, EGFR, MIR195, ERBB2, TP53
32
Hide members
8.6EGFR, CXCL10, IL10, IL8, ERBB2, TP53
338.3BRCA2, EGFR, RET, IL8, ERBB2, TP53

Compounds for genes affiliated with Primary Peritoneal Carcinoma

Sources:
45Novoseek, 60Tocris Bioscience, 11DrugBank, 24HMDB, 50PharmGKB, 29IUPHAR, 2BitterDB
See all sources

Compounds related to Primary Peritoneal Carcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 139)
idCompoundScoreTop Affiliating Genes
1cycloheximide4510.2BRCA2, BRCA1, CXCL10
2resveratrol45 60 11 2413.0ERBB2, PGR, BRCA2
3adriamycin4510.0CEACAM5, PGR
4tamoxifen45 50 29 1112.9ERBB2, EGFR, PGR
5dexamethasone45 50 29 1112.9MUC16
6vinorelbine45 1110.7BRCA1, EGFR, ERBB2, ERCC1
7fluticasone propionate45 50 60 1112.7IL8, CXCL10, PGR, IFNG
8anastrozole45 1110.6EGFR, PGR, ERBB2
9polyinosinic-polycytidylic acid459.6IL8, IL10, CXCL10, IFNG
10capecitabine45 50 1111.6PGR, ERBB2, EGFR
11il 10459.5IL8, IL10, CXCL10, IFNG
12tarc459.5IFNG, CXCL10, IL10, IL8
13taxane459.5EGFR, TP53, ERBB2, PGR
14ccl345 2910.5IL10, CXCL10, IFNG, IL8
15neopterin459.4IL10, IFNG, CXCL10, IL8
16etoposide45 50 60 1112.4BRCA1, BRCA2, ERCC1, ERBB2
17hydrocortisone45 2 60 1112.4ERBB2, IL8, IL10, CXCL10, IFNG
18suberoylanilide hydroxamic acid459.3IFNG, TP53, EGFR, ERBB2
19bortezomib45 1110.3TP53, ERBB2, EGFR, BRCA1
20methotrexate45 50 1111.3BRCA1, ERBB2, ERCC1, IL10, PGR, BRCA2
21exemestane50 45 60 1112.3EGFR, PGR, ERBB2
22leucovorin45 50 1111.2PGR, EGFR, CEACAM5, ERBB2
23adpribose459.2BRCA2, EGFR, TP53, BRCA1
244-hydroxytamoxifen459.2EGFR, BRCA1, BRCA2, IFNG, PGR, ERBB2
25gemcitabine45 50 1111.0TP53, EGFR, IL10, ERCC1, ERBB2, BRCA1
26thymidylate459.0ERBB2, IL10, BRCA1, TP53, ERCC1, EGFR
27herbimycin a45 609.9EGFR, ERBB2, IL8, RET, IFNG
28irinotecan45 50 1110.9TP53, CEACAM5, EGFR, ERCC1, ERBB2
29gold458.9CEACAM5, CXCL10, MUC16, BRCA2
30docetaxel45 50 60 1111.9ERBB2, PGR, ERCC1, TP53, BRCA2, EGFR
31melphalan45 119.8TP53, MUC16, IFNG, ERCC1
32mitomycin c458.8TP53, CEACAM5, ERCC1, IL10, BRCA2, BRCA1
33topotecan45 119.8TP53, ERBB2, MUC16, EGFR, BRCA1
34oxaliplatin45 50 1110.8BRCA1, EGFR, ERCC1, ERBB2, CEACAM5, TP53
35agar458.6PGR, BRCA1, EGFR, RET, ERBB2, CEACAM5
36ly294002458.6EGFR, RET, IL10, IL8, ERBB2, TP53
37cyclophosphamide45 50 1110.3TP53, IL10, ERBB2, ERCC1, BRCA1, MUC16
38thymidine45 249.2TP53, CXCL10, IL10, ERCC1, BRCA2, CEACAM5
39carboplatin45 50 1110.2MUC16, ERCC1, ERBB2, TP53, EGFR, IFNG
40retinoic acid45 249.2RET, PGR, TP53, IFNG, BRCA1, EGFR
415fluorouracil458.2CEACAM5, IFNG, EGFR, PGR, BRCA1, ERCC1
42genistein45 29 60 2 11 2413.1PGR, ERBB2, CXCL10, IL8, RET, EGFR
43phosphatidylinositol458.1ERCC1, RET, EGFR, BRCA1, BRCA2, ERBB2
44paclitaxel45 50 1110.0ERBB2, ERCC1, PGR, MUC16, BRCA1, BRCA2
45testosterone45 60 11 2411.0ERBB2, BRCA1, BRCA2, EGFR, MUC16, RET
46doxorubicin45 50 119.7ERBB2, CEACAM5, ERCC1, MUC16, EGFR, BRCA1
47cisplatin45 50 60 1110.7TP53, CEACAM5, ERBB2, ERCC1, EGFR, BRCA2
48progesterone45 60 29 11 2411.4EGFR, MUC16, PGR, CXCL10, ERBB2, CEACAM5
49paraffin456.8CEACAM5, BRCA1, BRCA2, EGFR, MUC16, TP53
50vegf456.0EGFR, IL8, IL10, CXCL10, PGR, RET

GO Terms for genes affiliated with Primary Peritoneal Carcinoma

Sources:
16Gene Ontology
See all sources

Cellular components related to Primary Peritoneal Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:0056158.1IL8, IL10, CXCL10, MUC16, EGFR, IFNG

Biological processes related to Primary Peritoneal Carcinoma according to GeneCards/GeneDecks:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of MHC class II biosynthetic processGO:0453489.9IFNG, IL10
2response to molecule of bacterial originGO:0022379.9IL8, IL10
3DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorGO:0069789.9BRCA1, BRCA2, TP53
4response to X-rayGO:0101659.8TP53, ERCC1, BRCA2
5response to gamma radiationGO:0103329.8BRCA2, CXCL10, TP53
6cellular response to estradiol stimulusGO:0713929.8IL10, EGFR
7nucleotide-excision repairGO:0062899.7BRCA2, ERCC1, TP53
8cellular response to lipopolysaccharideGO:0712229.7IFNG, IL10, IL8
9double-strand break repairGO:0063029.6TP53, ERCC1, BRCA2, BRCA1
10negative regulation of growth of symbiont in hostGO:0441309.5IL10, IFNG
11cell surface receptor signaling pathwayGO:0071669.5ERBB2, CXCL10, EGFR, IFNG
12cell proliferationGO:0082839.1EGFR, ERCC1, ERBB2, TP53
13positive regulation of transcription, DNA-dependentGO:0458939.0BRCA1, BRCA2, RET, IL10, TP53
14positive regulation of transcription from RNA polymerase II promoterGO:0459448.8BRCA1, IFNG, EGFR, IL10, TP53
15signal transductionGO:0071658.7EGFR, RET, PGR, CXCL10, IL8, ERBB2

Molecular functions related to Primary Peritoneal Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1epidermal growth factor-activated receptor activityGO:0050069.9ERBB2, EGFR
2receptor signaling protein tyrosine kinase activityGO:0047169.7ERBB2, EGFR
3transmembrane receptor protein tyrosine kinase activityGO:0047149.4ERBB2, RET, EGFR
4enzyme bindingGO:0198999.2BRCA1, EGFR, PGR, TP53
5protein tyrosine kinase activityGO:0047139.0EGFR, RET, ERBB2
6protein bindingGO:0055156.5BRCA2, EGFR, MUC16, RET, PGR, CXCL10

Products for genes affiliated with Primary Peritoneal Carcinoma

  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Primary Peritoneal Carcinoma

3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet